首页> 外文期刊>IAPAC monthly >Switching antiretroviral therapy:Why, when, and how
【24h】

Switching antiretroviral therapy:Why, when, and how

机译:转换抗逆转录病毒疗法:为什么,何时以及如何

获取原文
获取原文并翻译 | 示例
       

摘要

Once antiretroviral therapy (ART) is initiated, patients generally remain on medications indefinitely A switch in the antiretroviral (ARV) regimen is often necessary because of both acute and chronic toxicities, concomitant clinical conditions, and development of virologic failure The approach to patients who need to switch ART will differ depending on several issues, including the reason for change, the amount of previous ART experience, and the available treatment options. For example, when patients develop an adverse effect to a drug during their first ARV regimen, effective treatment may be easily accomplished by substituting another agent for the offending drug in the regimen. At the opposite end of the spectrum are patients with advanced HIV disease who have experienced toxicities, virologic failure,and drug resistance during multiple past treatment regimens and thus require a new treatment regimen. This article reviews these circumstances and provides clinical evidence and strategies for switching ART.
机译:一旦开始抗逆转录病毒治疗(ART),患者通常会无限期地使用药物。由于急性和慢性毒性,伴随的临床情况以及病毒学衰竭的发生,通常需要改变抗逆转录病毒(ARV)方案。切换ART的方式取决于几个问题,包括更改的原因,先前ART经验的数量以及可用的治疗选项。例如,当患者在他们的第一个ARV方案期间对药物产生不利影响时,可以通过在方案中用另一种药物代替有问题的药物来轻松实现有效的治疗。在频谱的另一端是晚期艾滋病毒患者,他们在过去的多种治疗方案中都经历过毒性,病毒学衰竭和耐药性,因此需要新的治疗方案。本文回顾了这些情况,并提供了切换ART的临床证据和策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号